Key statistics
On Friday, Akeso Inc (4RY:FRA) closed at 11.30, 52.70% above the 52 week low of 7.40 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.30 |
|---|---|
| High | 11.30 |
| Low | 11.30 |
| Bid | 11.30 |
| Offer | 11.50 |
| Previous close | 10.90 |
| Average volume | 766.67 |
|---|---|
| Shares outstanding | 921.14m |
| Free float | 717.29m |
| P/E (TTM) | -- |
| Market cap | 98.47bn HKD |
| EPS (TTM) | -1.10 HKD |
Data delayed at least 15 minutes, as of Feb 27 2026 08:55 GMT.
More ▼
Press releases
- Summit Therapeutics to Present at Upcoming Investor Conferences
- Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
- Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy
- Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK’s B7-H3 Antibody Drug Conjugate (ADC)
- Summit Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC
- Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
